Summary & Overview
CPT 86976: Serum Dilution for RBC Antibody Identification
CPT code 86976 denotes a laboratory immunohematology procedure in which serum is diluted to prepare samples for identification of antibodies against red blood cells. This preparatory dilution is a key step in antibody detection and characterization, supporting safe transfusion practices and management of alloimmunization. Nationally, accurate coding of this service informs laboratory reporting, reimbursement, and quality tracking in transfusion medicine.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose and typical site of service for CPT code 86976, plus an outline of common modifiers associated with the billing of laboratory procedures. The publication covers expected use cases in hospital and clinical laboratory settings and highlights what to consider for documentation and coding alignment.
This piece summarizes the clinical context and service definition for CPT code 86976, explains why the procedure matters for patient safety and transfusion management, and points to the types of benchmarks and policy factors that affect national implementation. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 86976 describes a laboratory procedure in which a lab analyst dilutes patient serum to prepare the sample for identification of antibodies to red blood cells (RBCs). This procedure is part of immunohematology testing used to detect and characterize RBC-directed antibodies that can cause transfusion reactions or hemolytic disease of the fetus and newborn.
-
Service type: Laboratory immunohematology preparation (serum dilution for RBC antibody identification)
-
Typical site of service: Clinical laboratory or hospital laboratory setting
Clinical & Coding Specifications
Clinical Context
A 45-year-old female with a history of chronic anemia is admitted for evaluation prior to a planned red blood cell transfusion. The transfusion service requests pretransfusion antibody screening and identification after the patient had prior transfusions and multiple pregnancies. A phlebotomy sample of serum is sent to the hospital immunohematology laboratory. The laboratory technologist performs serum dilution to prepare the sample for antibody identification against red blood cell (RBC) antigens using panel cells and indirect antiglobulin techniques. Results guide selection of antigen-negative blood units and determine whether further workup (e.g., eluate, adsorption) or specialist consultation is required.
Typical workflow:
-
Order placed by transfusion medicine or the treating clinician for antibody screen/identification.
-
Phlebotomy collects serum and labels specimen; specimen delivered to immunohematology laboratory.
-
Laboratory performs specimen handling: serum dilution (
86976), initial screening, and antibody identification assays. -
If clinically significant alloantibodies are identified, report to transfusion service and blood bank for antigen-negative unit selection and documentation in the patient’s transfusion record.
-
Results communicated to the clinical team and documented in the patient’s electronic medical record.